Addex Therapeutics Ltd (ADXN) — Cash Flow Quality Index
Latest as of June 2018:
1.52x
Addex Therapeutics Ltd (ADXN) has a Cash Flow Quality Index of 1.52x as of June 2018. Operating cash flow of CHF1.79 Million exceeds net income of CHF1.18 Million, indicating high earnings quality where cash backs reported profits. Explore Addex Therapeutics Ltd (ADXN) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
1.52x
Operating CF / Net Income
Operating Cash Flow
CHF1.79 Million
CHF
Net Income
CHF1.18 Million
CHF
Data as of
Jun 2018
Most recent filing
Annual Cash Flow Quality Index for Addex Therapeutics Ltd (None–None)
Year-by-year earnings quality comparison for Addex Therapeutics Ltd. For live market cap and the full company financial profile, see ADXN stock market capitalisation.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.